跳到主要內容

Saxonov Serge 的 Form 4 申報

10x Genomics, Inc.(TXG),2026/3/4 申報

申報編號
0001610717-26-000086
申報時間
2026/3/4
交易日
2026/3/2-3/3
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $36.7 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Saxonov SergeCIK 0001786720董事、高階主管(執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/3/2Class A Common StockS賣出處分−14,292$22.67F2−$323,999.641,205,527直接
2026/3/2Class A Common StockS賣出處分−1,860$23.18F3−$43,114.81,203,667直接
2026/3/3Class A Common StockG贈與處分−2,750$0.00$01,200,917直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $22.15 to $23.145, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F3

This transaction was executed in multiple trades at prices ranging from $23.15 to $23.25, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)